Personalized medicine, or precision medicine, aims to tailor treatments based on an individual's genetic profile. While this approach holds great promise, it also presents several challenges. For one, the genetic mutations driving cancer can vary widely between patients, requiring extensive and often costly genetic testing. Furthermore, even with detailed genetic information, predicting how a tumor will respond to a specific treatment remains complex.